Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kevin Nacho"'
Autor:
Maria Guadalupe Rodríguez-González, Kevin Nacho-Vargas, Tonatiuh Romero-Salas, Jorge Vela-Ojeda, Luis Meillon, Yamile Fattel, Yaneth Martinez-Ibarra, Moisés Xolotl-Castillo, Julio Robledo
Publikováno v:
Blood. 122:5236-5236
Introduction MDS are a heterogeneous group of acquired clonal diseases, characterized by an increase of the apoptosis and several grades of cytopenias. They originate in hematopoietic stem cells with cytogenetic and molecular abnormalities, having th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efa8bf26a4685fa633745870a24f225d
https://doi.org/10.1182/blood.v122.21.5236.5236
https://doi.org/10.1182/blood.v122.21.5236.5236
Autor:
Maria Mora, Angelica Romo, Nancy Delgado-Lopez, Noe Diaz-Robles, Yolanda Lugo, Carolina Sandoval-Sanchez, Patricia Oropeza, Manuel Ayala, Kevin Nacho-Vargas, Luis Meillon
Publikováno v:
Blood. 120:4452-4452
Abstract 4452 Background: Molecular Monitoring of BCR-ABL through standardized qPCR according to the international scale (IS) has been recently included in the follow-up of CML patients treated with tyrosine kinase inhibitors (TKIs) at the IMSS. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcfaa845eb839444af4dcf020dfdf022
https://doi.org/10.1182/blood.v120.21.4452.4452
https://doi.org/10.1182/blood.v120.21.4452.4452
Autor:
Jope DeDiego, Manuel Lopez, Lilia Aguilar, Oscar Perez, Mauricio Gonzalez, Laura Guzman, Yolanda Lugo, Rosa_Maria Arana, Christian Ramos, Alejandro Limon, Kevin Nacho, Gregorio Ignacio, Etha Rozen, Rosa María Romero Jiménez, Juan_Carlos Solis
Publikováno v:
Blood. 116:4864-4864
Abstract 4864 The t(9;22) or BCR/ABL fusion genes occurs in 20–30% of adult patients with ALL overall and its presence leads to worse prognosis for ALL. But there are a few large reports focused on this subtype of adult ALL in México, including i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb3e33960be0ce64a6ab6725a393c5ec
https://doi.org/10.1182/blood.v116.21.4864.4864
https://doi.org/10.1182/blood.v116.21.4864.4864
Autor:
Jorge Vela-Ojeda, Sergio Cleto, Nancy Delgado, Elena Garcia, Rafael Hurtado Monroy, Patricio Azaola, Juan J. Kassack, Norma Tapia, Alvaro Aguayo, Olga G. Cantu, Manuel Ayala, Martha Alvarado, Roberto Hernandez, Gustavo Reyes, Jose de Diego, Ingrid Mucius, Angel Herrera, Martín de Jesús Gonzalez, Kevin Nacho, Pablo Vargas, Luis Meillon
Publikováno v:
Blood. 112:4275-4275
Background: Nilotinib, a potent and highly selective BCR-ABL inhibitor, has been approved in more than 50 countries including Mexico. Nilotinib is indicated for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33c0d9c1f3008f3b21349a6685e71455
https://doi.org/10.1182/blood.v112.11.4275.4275
https://doi.org/10.1182/blood.v112.11.4275.4275
Autor:
Manuel Ayala, Alvaro Aguayo, Martha Alvarado, Norma Tapia, Angel Herrera, Kevin Nacho, Gustavo Reyes, Pablo Vargas, Yolanda Lugo, Sergio Cleto, Luis Meillon, Rafael Hurtado
Publikováno v:
Blood. 110:4578-4578
Background: Nilotinib is a novel tyrosine kinase inhibitor(TKI) developed for the treatment of Ph+ CML patients(pts) with intolerance or resistance to imatinib. Phase I and II studies have shown efficacy and safety of nilotinib, however access to cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::670fe853fb018b0d0361fb750c12925b
https://doi.org/10.1182/blood.v110.11.4578.4578
https://doi.org/10.1182/blood.v110.11.4578.4578
Autor:
Castellanos, Raúl Cano1, Ibarra, Martha Alvarado2, Pantoja, Emma Álvarez3, Arellano, Severiano Baltazar4, Galán, Jesús Elías Castellanos5, Rivera, Manuel Héctor Castillo6, Vargas, Guillermo Díaz7, Pérez, Roberto Hernández4, Hernández, Juan Manuel8, Hernández, José Mario9, Ibarra, Gregorio Ignacio10, Ipiña, Juan Julio Kassack11, Piña, Martín Loarca12, Fregoso, Sergio Loera, Guerrero, Abel Lomelí13, Narváez, Homero López3, Magaña, Elva María May, Montante, José Antonio5, Murillo, José Eduardo14, Vargas, Kevin Nacho15
Publikováno v:
Medicina Universitaria. jul-sep2008, Vol. 10 Issue 40, p159-167. 9p. 1 Diagram, 4 Charts.